NYSE:NVO

Novo Nordisk A/S SEC Filings & 10K Form

$66.00

-1.40 (-2.08 %)

(As of 11/24/2020 04:00 PM ET)

Add

Compare

Today's Range

$65.74

Now: $66.00▼

$66.34

50-Day Range

$63.89

MA: $69.07▼

$73.62

52-Week Range

$49.24

Now: $66.00▼

$73.81

Volume88,340 shs

Average Volume1.49 million shs

Market Capitalization$155.42 billion

P/E Ratio24.81

Dividend Yield1.09%

Beta0.43

Novo Nordisk A/S (NYSE:NVO) SEC Filings

Form Type:

Ownership Filings:

Date	Filer	Form Type
11/18/2020 5:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/17/2020 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/09/2020 7:17 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/09/2020 6:08 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/05/2020 8:49 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/04/2020 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/04/2020 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/04/2020 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/30/2020 8:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/29/2020 7:27 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

10/26/2020 9:38 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/19/2020 9:54 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/14/2020 6:48 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/08/2020 2:23 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/05/2020 8:53 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/28/2020 9:18 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/22/2020 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/14/2020 7:14 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/08/2020 5:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/31/2020 9:03 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/24/2020 9:24 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/17/2020 8:42 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/06/2020 11:21 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/06/2020 5:02 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/28/2020 6:46 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/20/2020 6:24 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/13/2020 6:29 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/06/2020 5:15 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/29/2020 9:52 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/29/2020 5:54 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/22/2020 8:03 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/18/2020 10:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/15/2020 7:27 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/12/2020 8:51 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/05/2020 5:01 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/03/2020 9:57 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/28/2020 10:11 AM	Novo Nordisk A/S (Filer)	Form SD Specialized Disclosure Report
05/26/2020 5:10 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/13/2020 11:17 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/12/2020 9:43 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/12/2020 5:19 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/12/2020 5:16 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/12/2020 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/11/2020 12:50 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/06/2020 6:16 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/05/2020 11:19 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/30/2020 11:33 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/30/2020 5:11 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/30/2020 5:06 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/28/2020 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/20/2020 10:43 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/06/2020 11:30 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/06/2020 5:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/31/2020 9:25 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/27/2020 5:01 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/26/2020 10:19 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/23/2020 9:39 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/17/2020 8:06 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/17/2020 7:33 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/09/2020 9:21 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/03/2020 12:05 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/28/2020 5:01 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/21/2020 5:10 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/14/2020 5:14 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/11/2020 8:49 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/11/2020 8:46 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/05/2020 11:16 AM	BlackRock Inc. (Filed by) Novo Nordisk A/S (Subject)	Form SC 13G/A
02/05/2020 8:49 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/05/2020 8:44 AM	Novo Nordisk A/S (Filer)	Form IRANNOTICE
02/05/2020 8:36 AM	Novo Nordisk A/S (Filer)	Form 20-F Registration statement / Annual report / Transition report
02/05/2020 7:59 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/04/2020 7:37 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/03/2020 6:00 AM	Innate Pharma SA (Subject) Novo Nordisk A/S (Filed by)	Form SC 13G
01/31/2020 10:29 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/27/2020 8:20 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/21/2020 5:30 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/17/2020 3:20 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/13/2020 10:04 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/30/2019 10:54 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/20/2019 8:08 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/18/2019 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/10/2019 7:08 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/03/2019 5:00 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/26/2019 5:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/20/2019 7:01 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/18/2019 9:16 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/18/2019 9:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/12/2019 5:30 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/07/2019 1:42 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/07/2019 1:41 PM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/06/2019 5:01 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/06/2019 5:01 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/01/2019 7:06 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/31/2019 9:39 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/28/2019 9:51 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/21/2019 8:25 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/15/2019 5:37 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/07/2019 9:26 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/01/2019 5:05 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/23/2019 9:44 AM	Novo Nordisk A/S (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

This page was last updated on 11/24/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Novo Nordisk A/S SEC Filings & 10K Form

Adding

Adding

Adding Novo Nordisk A/S

SEC Filings

Novo Nordisk A/S (NYSE:NVO) SEC Filings

30 Days of MarketBeat All Access for $1.00

Options Trading from Scratch

Market Data and Calendars

Investing Education and Resources